Manufacturing news briefs – stories you might have missed

Cell Therapies to manufacture Kymriah Melbourne contract manufacturer Cell Therapies has been given Therapeutic Goods Administration approval to manufacture Novartis’ chimeric antigen receptor T-cell at its facility at the Peter MacCallum Cancer Centre. The one-off treatment for blood cancers involves removing cells from the patient, reprogramming them and infuysing them back into the body. The…

Details

Australia and the UK collaborate to improve armour systems

Funding from Australia and the United Kingdom has been revealed for a major research program to improve armour systems for the military. The UK Government announced a bilateral international program to accelerate the integration of advanced materials into military platforms. Funding covers integration of composites, adhesives for structural joining, joining high temperature structures and improving…

Details